Principal investigator, Principal or Chief Investigator
Michael Dobbie
Related Websites
Associated with
Creating an immunocompetent preclinical prostate cancer model to investigate targeting a tumour-driving transcription factor to stop disease
10.82509/EV4R-K893
Associated with
Developing a humanized mouse model for Multiple Sclerosis
10.82509/G06Z-NZ80
Associated with
Developing novel models of cardiomyopathy for therapeutic testing
10.82509/MFZQ-Y642
Associated with
Developing rapid Pharmacodynamic AURKA Targeted Protein Degrader screening mice
10.82509/ZVFT-XP45
Associated with
Engineering genetic mouse models of severe childhood epilepsy to test the efficacy of venom peptides as a therapeutic strategy
10.82509/JX68-K477